Ayantunde Abraham A, Ng Ming Y, Pal Saurov, Welch Neil T, Parsons Simon L
Department of Surgery, Nottingham City Hospital, Hucknall Road, Nottingham NG5 1PB, UK.
BMC Surg. 2008 Jan 25;8:3. doi: 10.1186/1471-2482-8-3.
Oesophagectomy for cancers is a major operation with significant blood loss and usage. Concerns exist about the side effects of blood transfusion, cost and availability of donated blood. We are not aware of any previous study that has evaluated predictive factors for perioperative blood transfusion in patients undergoing elective oesophagectomy for cancer. This study aimed to audit the pattern of blood crossmatch and to evaluate factors predictive of transfusion requirements in oesophagectomy patients.
Data was collected from the database of all patients who underwent oesophagectomy for cancer over a 2-year period. Clinico-pathological data collected included patients demographics, clinical factors, tumour histopathological data, preoperative and discharge haemoglobin levels, total blood loss, number of units of blood crossmatched pre-, intra- and postoperatively, number of blood units transfused, crossmatched units reused for another patient and number of blood units wasted.Clinico-pathological variables were evaluated and logistic regression analysis was performed to determine which factors were predictive of blood transfusion.
A total of 145 patients with a male to female ratio of 2.5:1 and median age of 68 (40-85) years were audited. The mean preoperative haemoglobin (Hb) was 13.0 g/dl. 37% of males (Hb < 13.0 g/dl) and 29% of females (Hb < 11.5 g/dl) were anaemic preoperatively. A total of 1241 blood units were crossmatched and 316 units were transfused to 71 patients. Seventy four patients (51%) did not require blood transfusion during their hospital episode. 846 blood units not used for oesophagectomy patients were reused for other patients and 79 units were wasted. The overall crossmatch to transfusion ratio was 4:1 and reuse and wastage rates were 65.2% and 6.3% respectively. The independent predictors of blood transfusion include age >70 years, Hb level <11.0 g/dl, T-stage, presence of postoperative complications and anastomotic leak.
The cohort of patients audited was over-crossmatched. The identified independent predictors of blood transfusion should be considered in preoperative blood ordering for oesophagectomy patients. This study has directly led to a reduction in the maximum surgical blood-ordering schedule for oesophagectomy to 2 units and a reaudit is underway.
食管癌切除术是一项大型手术,术中失血量大且需大量输血。人们担心输血的副作用、成本以及献血的可获得性。我们不知道之前有任何研究评估过接受择期食管癌切除术患者围手术期输血的预测因素。本研究旨在审查血型交叉配血模式,并评估食管癌切除术患者输血需求的预测因素。
从2年内所有接受食管癌切除术患者的数据库中收集数据。收集的临床病理数据包括患者人口统计学资料、临床因素、肿瘤组织病理学数据、术前和出院时的血红蛋白水平、总失血量、术前、术中和术后交叉配血的血单位数量、输血的血单位数量、交叉配血后给其他患者复用的血单位数量以及浪费的血单位数量。对临床病理变量进行评估,并进行逻辑回归分析以确定哪些因素可预测输血情况。
共审查了145例患者,男女比例为2.5:1,中位年龄为68岁(40 - 85岁)。术前平均血红蛋白(Hb)为13.0 g/dl。术前37%的男性(Hb < 13.0 g/dl)和29%的女性(Hb < 11.5 g/dl)贫血。总共交叉配血1241个血单位,316个血单位输给了71例患者。74例患者(51%)在住院期间不需要输血。846个未用于食管癌切除术患者的血单位被用于其他患者,79个血单位被浪费。总体交叉配血与输血比例为4:1,复用率和浪费率分别为65.2%和6.3%。输血的独立预测因素包括年龄>70岁、Hb水平<11.0 g/dl、T分期、术后并发症的存在以及吻合口漏。
所审查的患者队列交叉配血过度。在为食管癌切除术患者进行术前备血时应考虑已确定的输血独立预测因素。本研究直接导致食管癌切除术的最大手术备血计划减少至2个单位,目前正在进行重新审查。